Dongwha Pharm.Co.Ltd (000020) — Cash Flow Reinvestment Rate
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow Reinvestment Rate of 5.88x as of March 2026, reinvesting ₩4.10 Billion (capex ₩3.71 Billion plus investments ₩390.62 Million) from operating cash flow of ₩697.02 Million. See 000020 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongwha Pharm.Co.Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Dongwha Pharm.Co.Ltd across 12 annual periods. For the full cash flow conversion analysis, see 000020 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Dongwha Pharm.Co.Ltd. See 000020 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.81x | ₩59.79 Billion | ₩15.70 Billion | ₩55.30 Billion | ▲ +280.3% |
| 2023 | 1.00x | ₩29.21 Billion | ₩29.17 Billion | ₩26.35 Billion | ▼ -37.7% |
| 2022 | 1.61x | ₩47.00 Billion | ₩29.22 Billion | ₩18.43 Billion | ▲ +144.1% |
| 2021 | 0.66x | ₩23.74 Billion | ₩36.03 Billion | ₩21.94 Billion | ▼ -29.9% |
| 2020 | 0.94x | ₩49.13 Billion | ₩52.23 Billion | ₩34.25 Billion | ▲ +20.0% |
| 2019 | 0.78x | ₩10.42 Billion | ₩13.28 Billion | ₩4.80 Billion | ▼ -39.3% |
| 2016 | 1.29x | ₩32.93 Billion | ₩25.48 Billion | ₩2.50 Billion | ▲ +2332.7% |
| 2015 | 0.05x | ₩1.05 Billion | ₩19.83 Billion | ₩885.50 Million | ▼ -83.2% |
| 2014 | 0.32x | ₩4.28 Billion | ₩13.51 Billion | ₩1.28 Billion | ▼ -84.0% |
| 2013 | 1.98x | ₩16.24 Billion | ₩8.21 Billion | ₩3.24 Billion | ▲ +142.7% |
| 2012 | 0.82x | ₩20.58 Billion | ₩25.23 Billion | ₩6.48 Billion | ▲ +305.1% |
| 2011 | 0.20x | ₩9.31 Billion | ₩46.24 Billion | ₩9.15 Billion | — |